Novel partners of S100A8 identified in laryngeal cancer cell lines

Chinese Journal of Medical Genetics

Volumn 24, Issue 3, 2007, Pages 266-270

  Fu, Wei Neng ^a   Guo, Yan ^a   Huang, Dai Fa ^a   Shang, Chao ^a   Sun, Kai Lai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Human leukocyte antigen B; Laryngeal carcinoma; NF kappa B pathway; S100A8

Indexed keywords

HLA B ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN S100A8; T BOX TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENESIS; COMPUTER PROGRAM; CONTROLLED STUDY; DNA FINGERPRINTING; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; LARYNX CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

ANIMALS; BINDING SITES; CALGRANULIN A; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HLA-B ANTIGENS; HUMANS; LARYNGEAL NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 34250858007     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Szyfter K. Molecular and cellular changes following exposure to tobacco smoke causing laryngeal cancer. An outline of the problem. Przegl Lek, 2004,61:1197-1199.
2. Hobbs CG, Birchall MA. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg, 2004,12:88-92.
3. Almadori G, Bussu F, Cadoni G, et al. Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur J Cancer, 2004,40:2383-2388.
4. Sadri M, McMahon J, Parker A. Laryngeal dysplasia: aetiology and molecular biology. J Laryngol Otol, 2006,120:170-177.
5. Fu WN, Shang C, Huang DF, et al. Average-12.9 chromosome imbalances coupling with 15 differential expression genes possibly involved in the carcinogenesis, progression and metastasis of supraglottic laryngeal squamous cell cancer. Chin J Med Genet, 2006,23:7-11.
6. Brigati C, Noonan DM, Albini A, et al. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis, 2002,19:247-258.
7. Gebhardt C, Breitenbach U, Tuckermann JP, et al. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene, 2002,21:4266-4276.
8. Cross SS, Hamdy FC, Deloulme JC, et al. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology, 2005,46:256-269.
9. Guo J, Yang EC, Desouza L, et al. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics, 2005,5:1953-1966.
10. Hermani A, Hess J, De Servi B, et al. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res, 2005,11:5146-5152.
11. Almadori G, Bussu F, Cadoni G, et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer, 2005,41:683-693.
12. Ott HW, Lindner H, Sarg B, et al. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Res, 2003,63:7507-7514.
13. Sunahori K, Yamamura M, Yamana J, et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther, 2006,8:R69.
14. Hermani A, de Servi B, Medunjanin S, et al. S100A8 and S100A9 activate MAP kinase and NF-kappa B signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res, 2006,312: 184-197.
15. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 1998,4: 328-332.
16. Theocharis S, Konstantopoulos K, Bannis K, et al. HLA-A and -B antigens and larynx carcinoma in Greeks. Ups J Med Sci, 1997,102:133-136.
17. Cabrera T, Salinero J, Fernandez MA, et al. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol, 2000, 61:499-506.
18. Gobin SJ, Keijsers V, van Zutphen M, et al. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol, 1998,161:2276-2283.
19. Wigle JT, Demchyshyn L, Pratt MA, et al. Molecular cloning, expression, and chromosomal assignment of sarcolemmal-associated proteins. A family of acidic amphipathic alpha-helical proteins associated with the membrane. J Biol Chem, 1997,272:32384-32394.
20. Marienfeld RB, Palkowitsch L, Ghosh S. Dimerization of the IKK-binding domain of NEMO is required for the TNF- {alpha} induced NF-{kappa} B activity. Mol Cell Biol, 2006,26:9209-9219.